Creatine fuels a universal energy regeneration system (phosphocreatine/ATP) present in muscle, brain, heart, bone, and immune cells. It is the most studied bioactive in the history of human supplementation, with over 500 published clinical trials. And the most interesting data have nothing to do with biceps.
They concern the brain. Bones. Mitochondria. Aging.
The phosphocreatine/ATP system: a universal energy buffer
To understand why creatine interests longevity researchers, we need to return to the fundamental mechanism. Creatine is an endogenous nitrogen-containing molecule, synthesized primarily in the liver and kidneys from three amino acids: arginine, glycine, and methionine. Once inside the cell, it is phosphorylated by the enzyme creatine kinase (CK) to form phosphocreatine (PCr).
Phosphocreatine acts as a molecular battery. When energy demand spikes (intense muscle contraction, sustained neuronal activity, cellular stress), PCr donates its phosphate group to ADP (the "spent" form of the energy molecule) to regenerate ATP (adenosine triphosphate, the universal energy currency of our cells) within milliseconds. This is faster than glycolysis (the breakdown of glucose to produce energy). Vastly faster than mitochondrial oxidative phosphorylation (the process by which mitochondria produce ATP using oxygen).
This system is not limited to skeletal muscle. Creatine kinase and phosphocreatine are present in the brain, heart, retina, bone cells, and immune cells (PubMed). Every tissue with high energy demand depends on this buffer. This universality explains why creatine's effects extend far beyond sport.
The human body stores roughly 120 g of creatine, 95% of which resides in skeletal muscle. Endogenous synthesis covers about 1 g/day, while diet (meat, fish) provides 1 to 2 g/day. Supplementation allows saturation of intracellular reserves.
Neuroprotection and cognition: the brain is a creatine-hungry organ
The brain represents 2% of body mass but consumes 20% of total energy. It is extremely dependent on the phosphocreatine/ATP system to maintain membrane potentials (the electrical signals that allow neurons to communicate), neurotransmission, and synaptic plasticity (the brain's ability to form and strengthen its connections). And unlike muscle, it cannot afford to slow down when energy runs low.
The first solid clinical data came from a randomized crossover trial published in the Proceedings of the Royal Society B. Six weeks of creatine monohydrate supplementation (5 g/day) produced a significant improvement in working memory and processing speed in healthy adults (PubMed). The effect was particularly pronounced on tasks with high cognitive load.
This finding was confirmed and extended by a 2018 meta-analysis pooling six randomized controlled trials. The conclusion: creatine supplementation improves short-term memory and reasoning, with a stronger effect in older adults and individuals under stress (sleep deprivation, mental fatigue) (PubMed). The stressed or aging brain benefits more from creatine than the young, rested brain. The logic follows the energy buffer principle: when reserves are low, exogenous supply makes the difference.
Vegetarians and vegans present a particularly instructive case. Their dietary creatine intake is zero (creatine comes exclusively from animal products). Their cerebral and muscular reserves are significantly lower. And these are precisely the populations that show the most pronounced cognitive gains after supplementation (PubMed).
Sarcopenia and muscle aging: robust data in older adults
Sarcopenia (the progressive loss of muscle mass and function with age) is one of the most reliable predictors of loss of autonomy, falls, and mortality in older adults. It begins silently around age 30 and accelerates after 60, with an estimated loss of 3 to 8% of muscle mass per decade.
Creatine is not an anabolic agent. It does not increase muscle protein synthesis on its own. Its mechanism is different and complementary: by increasing phosphocreatine stores, it enables higher-quality muscular work during exercise, which amplifies the mechanical stimulus required for muscle adaptation.
This is precisely what a major meta-analysis published in Medicine & Science in Sports & Exercise demonstrated. In adults over 50 engaged in resistance training, the addition of creatine monohydrate produced significantly greater gains in lean mass and strength compared to exercise alone (PubMed). The key point: creatine without exercise produces little effect. It is the interaction between the two that generates the benefit.
A 12-month clinical trial in postmenopausal women pushed the analysis further. Creatine combined with resistance training versus exercise alone. The creatine group showed significantly superior preservation of functional strength and bone quality markers at the femoral neck (PubMed).
Bone health and mitochondrial metabolism
The effect of creatine on bone tissue is an emerging field, but one that is biologically coherent. Osteoblasts (the cells that build bone) are high-energy-demand cells. They express creatine kinase and use the phosphocreatine/ATP system to fuel bone matrix synthesis. Increasing creatine availability in these cells could support their activity.
Preclinical data are convergent. In vitro, creatine stimulates osteoblast differentiation and increases mineralization (PubMed). In vivo, combined with resistance exercise in postmenopausal women, it has shown positive effects on bone mineral density in several trials.
At the mitochondrial level, the data are equally compelling. Mitochondrial creatine kinase (MtCK) forms functional complexes with porins (protein channels) on the outer mitochondrial membrane. This coupling enables direct energy transfer between the mitochondrial matrix (the interior of the mitochondrion, where ATP is manufactured) and the cytoplasm (the cell's internal fluid), optimizing the efficiency of oxidative phosphorylation. In other words, creatine does not merely buffer ATP. It improves the way mitochondria produce it.
Studies in animal models have shown that creatine supplementation reduces lipofuscin accumulation (a marker of cellular aging) and increases median lifespan in mice (PubMed). Extrapolating directly to humans would be premature. But the mechanism is consistent with what we know about the role of cellular energy in longevity.
Monohydrate vs other forms: the science is clear
The supplement industry has multiplied creatine forms over the years: ethyl ester, hydrochloride (HCl), kre-alkalyn (buffered), nitrate, pyruvate, magnesium chelate. Each claims superior absorption or reduced side effects.
The scientific reality is unambiguous. The official position of the International Society of Sports Nutrition (ISSN) is clear: creatine monohydrate is the most studied and most effective form (PubMed). No other form has demonstrated superiority in bioavailability, efficacy, or safety in head-to-head trials.
Creatine ethyl ester, for example, partially degrades into creatinine (an inactive metabolic waste product) before it even reaches the muscle. Kre-alkalyn, despite its promises of better absorption at high gastric pH, showed no advantage over monohydrate in controlled trials. Monohydrate has a bioavailability of approximately 99% when consumed with a meal.
The pricing reflects this reality: monohydrate is the least expensive and most documented form. Paying more for an alternative form means paying for marketing, not science.
Myth-busting: persistent misconceptions
Creatine damages the kidneys. This is the most persistent myth, and the most unfounded. It stems from a confusion between creatine and creatinine. Creatinine is a kidney filtration marker whose levels naturally rise with creatine supplementation (since creatine degrades into creatinine). But elevated creatinine from supplementation does not reflect kidney dysfunction.
Long-term studies (up to 5 years of continuous supplementation) have shown no adverse effects on kidney function in healthy individuals (PubMed). Even in individuals with a single functioning kidney, creatine did not impair glomerular filtration in available data. It is absurd that this myth persists in the face of such a volume of evidence.
Creatine causes excessive water retention. Creatine is osmotically active (it attracts water through a natural physical effect): it draws water into the muscle cell. That is a fact. But this retention is intracellular, not subcutaneous. It is not comparable to edema or sodium-related fluid retention. The initial weight gain (0.5 to 1.5 kg in the first weeks) corresponds to cellular hydration, a marker of healthy cell function, not a side effect.
Creatine is a steroid or stimulant. Creatine is neither anabolic nor stimulant. It does not alter hormone levels (testosterone, cortisol, IGF-1). It is not classified as a banned substance by the World Anti-Doping Agency.
Optimal calibration for longevity
The sports literature popularized the "loading phase": 20 g/day for 5 to 7 days, followed by maintenance at 3-5 g/day. This protocol saturates muscle stores quickly, but it is not necessary for a longevity objective.
The evidence-based approach is simpler. A daily intake of 3 to 5 g of creatine monohydrate, without a loading phase, saturates stores in 3 to 4 weeks and maintains stable levels (PubMed). Taking it with a meal containing carbohydrates and protein improves absorption via insulin stimulation.
For older adults or individuals with low muscle mass, some authors suggest a body-weight-adjusted calibration: 0.07 to 0.1 g/kg/day. This yields approximately 5 to 7 g/day for a 70 kg individual. Cycling (on/off periods) is not supported by any scientific data and provides no documented benefit.
Consistency outweighs intensity. The phosphocreatine buffer depletes within days without intake. Daily regularity is the only variable that matters.
Creatine monohydrate is one of the rare bioactives for which the benefit-to-risk ratio is this favorable and this thoroughly documented. Three decades of research have failed to identify a significant adverse effect at recommended doses. Meanwhile, they have continued to reveal new domains of action: cognition, bone density, mitochondrial function, resistance to muscle aging.
The next frontier is human longevity trials. Animal models are encouraging. The cellular mechanisms are coherent. What is missing are prospective data over 5 to 10 years measuring the impact of chronic creatine supplementation on functional aging endpoints: cognitive capacity, fall risk, autonomy, body composition. These trials are underway. Their results will determine whether creatine deserves reclassification as a full-fledged longevity tool.
Frequently asked questions
References
- Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18 (PubMed).
- Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proc Biol Sci. 2003;270(1529):2147-2150 (PubMed).
- Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D. Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials. Exp Gerontol. 2018;108:166-173 (PubMed).
- Benton D, Donohoe R. The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. Br J Nutr. 2011;105(7):1100-1105 (PubMed).
- Devries MC, Phillips SM. Creatine supplementation during resistance training in older adults — a meta-analysis. Med Sci Sports Exerc. 2014;46(6):1194-1203 (PubMed).
- Chilibeck PD, Candow DG, Landeryou T, Kaviani M, Paus-Jenssen L. Effects of creatine and resistance training on bone health in postmenopausal women. Med Sci Sports Exerc. 2015;47(8):1587-1595 (PubMed).
- Gerber I, ap Gwynn I, Alini M, Wallimann T. Stimulatory effects of creatine on metabolic activity, differentiation and mineralization of primary osteoblast-like cells in monolayer and micromass cell cultures. Eur Cell Mater. 2005;10:8-22 (PubMed).
- Bender A, Beckers J, Schneider I, et al. Creatine improves health and survival of mice. Neurobiol Aging. 2008;29(9):1404-1411 (PubMed).
